Allianz Asset Management GmbH Boosts Holdings in Maximus, Inc. $MMS

Allianz Asset Management GmbH boosted its position in shares of Maximus, Inc. (NYSE:MMS) by 38.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 233,348 shares of the health services provider’s stock after buying an additional 64,249 shares during the quarter. Allianz Asset Management GmbH owned 0.41% of Maximus worth $16,381,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC boosted its stake in Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider’s stock worth $50,000 after buying an additional 294 shares during the period. Blue Trust Inc. boosted its stake in Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider’s stock worth $84,000 after buying an additional 303 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Maximus during the first quarter worth $2,115,000. Janney Montgomery Scott LLC boosted its stake in Maximus by 70.5% during the first quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider’s stock worth $692,000 after buying an additional 4,196 shares during the period. Finally, Oppenheimer Asset Management Inc. boosted its stake in Maximus by 24.0% during the first quarter. Oppenheimer Asset Management Inc. now owns 6,461 shares of the health services provider’s stock worth $441,000 after buying an additional 1,249 shares during the period. 97.21% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on MMS shares. Zacks Research raised shares of Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 26th. Weiss Ratings raised shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the stock. According to MarketBeat, Maximus has a consensus rating of “Buy” and a consensus target price of $90.00.

Maximus Stock Up 2.3%

NYSE:MMS opened at $87.15 on Tuesday. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.73. The company has a 50-day moving average of $87.56 and a 200 day moving average of $76.88. The firm has a market cap of $4.91 billion, a PE ratio of 16.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same period in the prior year, the firm earned $1.74 earnings per share. The firm’s revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Investors of record on Friday, November 14th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus’s dividend payout ratio is 22.10%.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 1,610 shares of the business’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider directly owned 13,508 shares in the company, valued at approximately $1,227,336.88. The trade was a 10.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by company insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.